Aquilon Pharma is a Belgium-based startup that aims to revolutionize the efficacy of inhaled drugs. Founded in 2013, the company focuses on developing value-added medicines to enhance the effectiveness of inhaled drugs. With its stronghold in the health care and pharmaceutical industries, Aquilon Pharma presents an innovative approach to drug delivery and treatment. Despite not having any information about its last investment or investors, Aquilon Pharma's dedication to improving drug delivery methods makes it a promising prospect for venture capital firms looking to invest in cutting-edge healthcare solutions.
General Information
BounceWatch is an independent company data service, not affiliated with Aquilon Pharma. To contact Aquilon Pharma, visit aquilonpharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Belgium Market
Health Care
About Aquilon Pharma
Taxonomy: pharmaceuticals, inhaled drugs, drug efficacy, medicine development, respiratory care, drug delivery, pharmaceutical research, medical innovation
No funding data available for Aquilon Pharma yet.
Aquilon Pharma Alternatives & Competitors
View All AlternativesTransforming The Delivery of Inhaled Nitric Oxide
Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...
With state-of-the-art facilities and a pioneering team, we bring advanced generic drugs to the U.S....
FAQ About Aquilon Pharma
Source: BounceWatch company record for Aquilon Pharma, https://bouncewatch.com/company/aquilon-pharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.